Clinical decision support
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
It has also received Australia's regulatory approval for its AI solution.
Also, Kakao Healthcare is extending access to its AI to a public diabetes screening programme in South Korea.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Also, insurtech company Huize from China is expanding to Southeast Asia.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Interestingly, young physicians see more risk to it than their senior counterparts.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.